CLINICAL TRIALS PROFILE FOR ABILIFY MYCITE KIT

All Clinical Trials for ABILIFY MYCITE KIT

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT03643159 ↗	A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder	Terminated	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 4	2018-06-28	The primary objective of this pragmatic clinical trial (Main Study) was to assess the difference between all-cause hospitalizations in participants using Abilify MyCite versus virtual matched controls. In addition, secondary and exploratory objectives were to assess medication adherence, healthcare utilization and costs, and patient-reported outcomes.

Clinical Trial Conditions for ABILIFY MYCITE KIT

Condition Name

Condition Name for ABILIFY MYCITE KIT
Intervention	Trials
Bipolar 1 Disorder	1
Bipolar I Disorder	1
Major Depressive Disorder	1
Schizophrenia	1

Condition MeSH

Condition MeSH for ABILIFY MYCITE KIT
Intervention	Trials
Depressive Disorder	1
Depression	1
Schizophrenia	1
Disease	1

Clinical Trial Locations for ABILIFY MYCITE KIT

Trials by Country

Trials by Country for ABILIFY MYCITE KIT
Location	Trials
United States	4

Trials by US State

Trials by US State for ABILIFY MYCITE KIT
Location	Trials
Ohio	1
Nevada	1
Georgia	1
California	1

Clinical Trial Progress for ABILIFY MYCITE KIT

Clinical Trial Phase

Clinical Trial Phase for ABILIFY MYCITE KIT
Clinical Trial Phase	Trials
Phase 4	1

Clinical Trial Status

Clinical Trial Status for ABILIFY MYCITE KIT
Clinical Trial Phase	Trials
Terminated	1

Clinical Trial Sponsors for ABILIFY MYCITE KIT

Sponsor Name

Sponsor Name for ABILIFY MYCITE KIT
Sponsor	Trials
Otsuka Pharmaceutical Development & Commercialization, Inc.	1

Sponsor Type

Sponsor Type for ABILIFY MYCITE KIT
Sponsor	Trials
Industry	1